EN2: A candidate antigen for the development of targeted therapies in ovarian cancer.

Michael, A, Riley, C, Bokaee, S, Denyer, M, Pandha, HS and Annels, NE (2011) EN2: A candidate antigen for the development of targeted therapies in ovarian cancer. JOURNAL OF CLINICAL ONCOLOGY, 29 (15).

Full text not available from this repository.

Item Type:	Article
Divisions :	Surrey research (other units)
Authors :	Name Email ORCID Michael, A a.michael@surrey.ac.uk Riley, C Bokaee, S Denyer, M Pandha, HS h.pandha@surrey.ac.uk Annels, NE n.annels@surrey.ac.uk
Date :	20 May 2011
Uncontrolled Keywords :	Science & Technology, Life Sciences & Biomedicine, Oncology
Related URLs :	Author
Depositing User :	Symplectic Elements
Date Deposited :	17 May 2017 10:13
Last Modified :	24 Jan 2020 18:46
URI:	http://epubs.surrey.ac.uk/id/eprint/826910

Actions (login required)

View Item

Downloads